Chembio Diagnostics, Inc. (CEMI) financial statements (2022 and earlier)

Company profile

Business Address 555 WIRELESS BLVD.
HAUPPAUGE, NY 11788
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments28,773 18,27112,5253,79010,554
Cash and cash equivalents28,773 18,27112,5253,79010,554
Receivables11,441 3,6617,3742,0853,384
Inventory, net of allowances, customer advances and progress billings12,920 9,5987,8514,4243,335
Inventory12,920 9,5987,8514,4243,335
Other undisclosed current assets1,710 693702554840
Total current assets:54,845 32,22428,45210,85418,114
Noncurrent Assets
Finance lease, right-of-use asset192 210
Operating lease, right-of-use asset5,892 7,031
Property, plant and equipment8,557 5,9342,8741,9091,709
Intangible assets, net (including goodwill)6,073 9,7878,8683,264 
Goodwill3,023 5,8734,9831,667 
Intangible assets, net (excluding goodwill)3,050 3,9143,8851,597 
Deposits noncurrent assets744 544718589720
Other undisclosed noncurrent assets(3,050)    32
Total noncurrent assets:18,408 23,50512,4595,7622,462
TOTAL ASSETS:73,252 55,72940,91116,61620,575
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:13,128 5,5265,8893,0463,013
Accounts payable7,746 3,1443,6231,4951,437
Accrued liabilities1,728 5931,458772836
Employee-related liabilities2,294 857808780740
Other undisclosed accounts payable and accrued liabilities1,360 932   
Deferred revenue  125
Debt1,268 790208  
Deferred revenue and credits50393
Contract with customer, liability423
Other undisclosed current liabilities886     
Total current liabilities:15,282 6,4426,5193,0963,406
Noncurrent Liabilities
Long-term debt and lease obligation23,705 24,78617299 
Long-term debt, excluding current maturities17,589 17,64417299 
Finance lease, liability140 172
Operating lease, liability5,976 6,970
Liabilities, other than long-term debt  466892341 
Deferred tax liabilities, net892341 
Deferred income tax liabilities  466
Other undisclosed noncurrent liabilities(5,976)     
Total noncurrent liabilities:23,705 25,2521,064441 
Total liabilities:38,987 31,6947,5833,5373,406
Stockholders' equity
Stockholders' equity attributable to parent34,265 24,03533,32813,07917,170
Common stock301 177172123120
Treasury stock, value(207)     
Additional paid in capital165,773 95,43390,95462,82160,722
Accumulated other comprehensive income (loss)(592) 10112179 
Accumulated deficit(131,010) (71,585)(57,910)(50,044)(43,672)
Total stockholders' equity:34,265 24,03533,32813,07917,170
TOTAL LIABILITIES AND EQUITY:73,252 55,72940,91116,61620,575

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues47,818 34,46433,40924,01517,869
Revenue, net24,01517,869
Cost of revenue(34,496) (22,394)(21,427)(12,921)(9,418)
Cost of goods and services sold(4,055)  (21,427)(12,921)(9,418)
Gross profit:13,323 12,07011,98211,0948,451
Operating expenses(43,292) (25,398)(41,392)(30,498)(16,023)
Other undisclosed operating income (loss)(1,084)  21,42712,921 
Operating loss:(31,053) (13,329)(7,983)(6,483)(7,572)
Nonoperating income   492226
Investment income, nonoperating   49  
Other nonoperating income    2226
Interest and debt expense(20) (8) (3) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  (839) 3 
Loss from continuing operations before equity method investments, income taxes:(31,073) (14,175)(7,933)(6,460)(7,546)
Other undisclosed loss from continuing operations before income taxes(2,892)     
Loss from continuing operations before income taxes:(33,966) (14,175)(7,933)(6,460)(7,546)
Income tax expense (benefit)62 5006888(5,801)
Net loss available to common stockholders, diluted:(33,904) (13,675)(7,866)(6,372)(13,347)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(33,904) (13,675)(7,866)(6,372)(13,347)
Comprehensive loss:(33,904) (13,675)(7,866)(6,372)(13,347)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(501) (102)(67)179 
Comprehensive loss, net of tax, attributable to parent:(34,405) (13,777)(7,932)(6,193)(13,347)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: